Maze Therapeutics, Inc. · NASDAQ:MAZE

James N. Topper reported a 9.40% stake in Maze Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 29, 2025

James N. Topper reported a 9.40% stake in Maze Therapeutics, Inc., 4,129,000 shares, as a passive investor on Mar 31, 2025. Filed Apr 29, 2025 (Schedule 13G/A).

Stake: 9.40%
Shares: 4,129,000
Intent: Passive
What changed: Stake changed
Filed together: 17 holders

The filing in full

Holder	Stake	Shares
Frazier Life Sciences Public Fund, L.P.	7.00%	3,044,573
FHMLSP, L.P.	7.00%	3,044,573
FHMLSP, L.L.C.	7.00%	3,044,573
Frazier Life Sciences Public Overage Fund, L.P.	2.10%	898,383
FHMLSP Overage, L.P.	2.10%	898,383
FHMLSP Overage, L.L.C.	2.10%	898,383
Frazier Life Sciences X, L.P.	0.20%	66,677
FHMLS X, L.P.	0.20%	66,677
FHMLS X, L.L.C.	0.20%	66,677
Frazier Life Sciences XI, L.P.	0.30%	119,367
FHMLS XI, L.P.	0.30%	119,367
FHMLS XI, L.L.C.	0.30%	119,367
James N. Topper	9.40%	4,129,000
Patrick J. Heron	9.40%	4,129,000
Albert Cha	9.00%	3,942,956
James Brush	9.00%	3,942,956
Daniel Estes	0.30%	119,367

Source

View original at SEC

Related